- Israel-based InMode Aesthetic Solutions has raised $70 million on its Nasdaq initial public offering Thursday, listing under the ticker INMD. InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million. The company closed 3.3 percent up on Friday.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEo0tPObY0WrdtZmgTf07SwTim4CtZy3FvdzyIQRB4tNs-EvHL68Wg9ULPZkLIR8T3H9GjOho83U-k2N0qXIX5TBculMN5rFvsc-1ThB2FrNMwkg_ESA7FfzPiOV_u404PW5PkGvumlM8/s1600/INMD-i.jpg)
InMode was founded as Invasix in 2008 by CEO and chairman Moshe Mizrahi, one of the founders of Israel-based medical device company Syneron Medical Ltd. Prior to the IPO, Mizrahi held a 20.6% stake in InMode. In 2006, Mizrahi co-founded home aesthetics device developer Home Skinovations Ltd., which he previously tried to list three times, the latest earlier this year according to a $300 million company valuation.
No comments:
Post a Comment